SciCombinator

Discover the most talked about and latest scientific content & concepts.

CH Lee, YB Lee, MA Kim, H Jang, H Oh, SW Kim, EJ Cho, KH Lee, JH Lee, SJ Yu, JH Yoon, TY Kim and YJ Kim
Abstract
Several treatment options are currently available for patients with hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare the effectiveness of regorafenib and nivolumab in these patients.
Tweets*
0
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
0
Concepts
-
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com